Share Share this content Opens in a new window Opens in a new window Opens in a new window Opens in a new window OPA's Submission Letter to OCP Bill 179 You may be interested in Nirmatrelvir/Ritonavir (Paxlovid) Prescribing December 12, 2022 Post category: Advocacy Become a Pharmacist October 28, 2020 Post category: Advocacy Update on the Pharmacy Profession October 29, 2020 Post category: Advocacy Joint OPA NPAC Submission on COVID-19 Copayment Relief Proposal May 2, 2020 Post category: Advocacy
